会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • SUBSTANCE LIBRARY
    • 物质库
    • WO01047882A2
    • 2001-07-05
    • PCT/EP2000/012973
    • 2000-12-20
    • B01J19/00C07D209/00
    • C07D209/00B01J19/0046B01J2219/00691B01J2219/0072
    • The invention relates to a substance library which can be obtained by reaction of aromatic aldehyde compounds and/or heteroaromatic aldehyde compounds and/or aliphatic aldehyde compounds without an acid proton in a-position in a solution in the presence of a base with secondary amines to produce aminal compounds; reaction of said aminal compounds without any further purification with acid chlorides in an absolute solvent to produce iminium salts; reaction thereof without any further purification in an organic solvent with unsubstituted or substituted naphthol, pyrrole and/or indole compounds; purification and isolation of the compounds thus obtained according to the usual methods and optionally, reaction of the naphthol and/or indol compounds thus obtained in a solution with organic halogen compounds in the presence of a base and optionally, purification by filtration and isolation of the naphthol and/or indol compounds thus obtained according to the usual methods. The invention also relates to the use of said substance library for the detection of active ingredients.
    • 本发明涉及一种物质库,它们的制备方法和用于发现活性物质的用途,该物质库的过程。
    • 3. 发明申请
    • CYCLOPROPANECARBOXYLATE ESTERS OF PURINE ANALOGUES
    • 嘌呤类似物的环糊精羧酸酯
    • WO2013158367A1
    • 2013-10-24
    • PCT/US2013/035042
    • 2013-04-02
    • ANNJI PHARMACEUTICAL CO., LTD.HEALTHBANKS USA INC.
    • CHERN, Ji-WangLAI, Shin-YuCHANG, Pei-Teh
    • A61K31/522
    • C07D209/34A61K31/522A61K38/45C07D209/00C07D401/06C07D401/14C07D403/06C07D403/14C07D405/06C07D409/06C07D473/32
    • Cydopropanecarboxylate esters of purine analogues, method of making and using the same for treating herpes virus infections and tumors are disclosed. In an embodiment of the invention, the compound of the invention may be used for treating cancer A cancer patient may be first administered a vector, such as an adenovector, comprising a DNA insert encoding HSV thymidme kinase, said vector expressing HSV thymidine kinase in the tumor cells of the subject, followed by administration of the compound of the invention. In another aspect the invention relates to use of a compound or a pharmaceutically acceptable salt, a solvate or hydrate, a prodrug, or a metabolite thereof as aforementioned in the manufacture of a medicament for treating herpes virus infection. The medicament may be for treating herpes simplex virus infection, herpes zoster infection, or cytomegalovirus infection.
    • 公开了嘌呤类似物的环丙烷羧酸酯,其制备方法和用于治疗疱疹病毒感染和肿瘤的方法。 在本发明的一个实施方案中,本发明的化合物可用于治疗癌症。癌症患者可以首先施用载体,例如腺病毒载体,其包含编码HSV胸腺嘧啶激酶的DNA插入片段,所述载体在HSV胸苷激酶中表达HSV胸苷激酶 受试者的肿瘤细胞,然后施用本发明的化合物。 在另一方面,本发明涉及如上所述的化合物或其药学上可接受的盐,其溶剂化物或水合物,前药或代谢物在制备用于治疗疱疹病毒感染的药物中的用途。 药物可用于治疗单纯疱疹病毒感染,带状疱疹感染或巨细胞病毒感染。